IT’S TIME..!
SXSW 2026|Panel Picker

Your vote gets patient stories and research on the stage…
...and takes just two minutes to complete

Click link below and add a ♥️ to our panel

From Practice to Proof: Psychedelics for Physical Conditions

participate.sxsw.com/flow/sxsw/sx...

remaptherapeutics.com
5/

How the extended REMAP Protocol post-immersion can lead to an extensive & stable period of remission.

*JOIN US*

Limited to 5 participants.
Late Fall | Early Winter
Onsite physiotherapist &
psychiatric nurse practitioner

Serious inquiries can fill out our application
form at REMAP Therapeutics
4/

We’ll explore in depth... Our Six-week PREMAPPING segment analyses your individual sensorimotor deficits. Identify your unique neuromodulatory techniques. Educating you in the striking parallels between pain & psychedelic neuroscience.
3/

Lynn’s Story

20+ years severe chronic pain
went 15+ months into remission

CRPS, full-body, type-II
Severe Foot Neuromas
Glossodynia
(aka Burning Mouth syndrome)
PTSD & Depression
2/

REMAP Retreats

Late Fall | Early Winter

Psilocybin & the REMAP Protocol
relieved years of complex chronic pain
in a US Veteran

Harm-reduction & Pain Neuromodulation Coaching

Three month program with 1-week Live Immersion in legal locality
1/

PSYCHEDELICS & PAIN SYMPOSIUM 2025
SEPTEMBER 27th & 28th ONLINE

Two days of expert presenters from universities around the globe, preliminary study results, patient stories of healing & regained function through the use of psychedelics for their pain & physical conditions.

REGISTRATION COMING SOON

TODAY!
We’ll be moderating a panel @mapsorg.bsky.social Psychedelic Science 2025 in Denver, with @robincarhartharris.bsky.social, Dr. Charles Nichols, and Dr. Candace Lewis.

“Expanding the Lens: Mechanisms, Models & Modes - Transdiagnostic Potential of Psychedelic Medicines”

#PS2025

Jody Lance, a Canadian w/ cluster headaches, secured legal psilocybin access a 2nd time—w/ legal action by Nicholas Pope and advocacy by @therapsil.bsky.social. This highlights urgency for ongoing, regulated access to psychedelic therapies for patients w/ severe conditions.

Story: therapsil.ca/news

"This panel brings together leading researchers to explore points of convergence and divergence among these models. Do they represent competing or complementary mechanisms? How do they interpret changes in sensory processing, cortical reorganization, and neural stability?"

#PS2025
4/

...Dr. Charles Nichols/LSU, key researcher on anti-inflammatory properties of psychedelics, and Dr. Candace Lewis/ASU, highlighting HPA axis gene expression improvements in treating PTSD patients with MDMA-AT.

#PS2025
3/

Wednesday June 18th at 12:15pm in the Mile High Ballroom, 4B, I'll represent both REMAP Therapeutics and the Psychedelics & Pain Association.

An involving discussion between Dr. @robincarhartharris.bsky.social/UCSF, noted for his neuroimaging of cortical reorganization in PAT,...

#PS2025
2/

Excited to share we’ll be moderating a panel @mapsorg.bsky.social Psychedelic Science 2025 in Denver, with @robincarhartharris.bsky.social, Dr. Charles Nichols, and Dr. Candace Lewis.

“Expanding the Lens: Mechanisms, Models & Modes - Transdiagnostic Potential of Psychedelic Medicines”

#PS2025
1/

Two announcements:
Moderating a panel at SXSW - "Beyond the Mind: Psychedelics to Heal the Body" on March 10 / 4pm, with Julia Bornemann - Imperial College, Dr. Joel Castellanos - UCSD, and Prof. Garcia-Romeu - Johns Hopkins, on psychedelics & physical conditions
schedule.sxsw.com/2025/events/...
1/

Vaguely reminiscent: